MammoScreen 2.0
by Therapixel
510(k) K211541
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE 510(k) | NumberK211541 | Date26 Nov 2021 | StatusActive |
| European Union | CE/MDD EUDAMED | Number— | Date— | StatusActive |
Official records
From the FDA record
- Received by the FDA
- 19 May 2021
- FDA decision
- 26 Nov 2021 (Substantially Equivalent)
- FDA review time
- 191 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Across registries
- FDA 510(k) K211541 decided 26 Nov 2021 Active
- EUDAMED Active
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- 510(k) Number
- FDA product code
- QDQ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2090
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
MammoScreen 2.0 is a Radiological Computer Assisted Detection/Diagnosis Software for Lesions Suspicious for Cancer, designed to assist radiologists in the analysis of mammographic images. It employs AI-based algorithms to detect and evaluate suspicious lesions in both 2D and 3D mammograms, enhancing diagnostic accuracy and workflow efficiency.
This software is supplied as a digital solution, intended for use in radiology departments within healthcare facilities. It operates as a standalone application, requiring no physical sterilisation or single-use considerations, and is compatible with standard MRI-safe environments. The device is authorised under FDA 510K and MDD, with a classification of Class II. Multiple registration numbers (e.g., 3023522713) correspond to its various software versions and configurations.
Devices cleared under K211541
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| MammoScreen MAL2US | MAL2US | B885MAML2US0 | — | On the market |
Similar devices
Other devices filed under FDA product code QDQ (Radiological Computer Assisted Detection/Diagnosis Software For Lesions Suspicious For Cancer).
- Transpara by Screenpoint Medical B.V.
- Genius AI Detection by Hologic, Inc.
- ProFound AI Software V3.0 by Icad, Inc.
- Saige-Dx by DEEPHEALTH
- SMART-T Thyroid by See-Mode Technologies Pte, Ltd.
- CadAI-B Dx by BeamWorks Inc.
- QP-Prostate CAD by QUIBIM S.L.
- PowerLook Tomo Detection V2 Software by Icad, Inc.
- Genius AI Detection 2.0 with CC-MLO Correlation by Hologic, Inc.
- Lunit Insight MMG (v1.1.10) by Lunit Inc.